Showing results (331-340 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|December 19, 2019
Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric MedicationsJulie-Anne Tanner, Lisa C Brown, Kunbo Yu, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 28, 2020
Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental IllnessFelicia Forma, Teresa Green, Seung Kim, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 26, 2019
Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumabLorie A Ellis, Elisabetta Malangone-Monaco, Helen Varker, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 18, 2020
Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims DatabasesKrista M Schroeder, Steve Gelwicks, April N Naegeli, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 22, 2019
Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countriesKaoru Yamabe, Marco D DiBonaventura, Chris L Pashos
Clinicoeconomics and Outcomes Research : CEOR|December 12, 2018
Impact of postcolectomy adhesion-related complications on healthcare utilizationKatherine Etter, Nadia Sutton, David Wei, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 21, 2025
Evaluating the Economic Impact of Diabetes Mellitus: A Hospital-Centric Cost Analysis in Hail, Saudi ArabiaAbdullah Mohammad Alshammari, Mohamed Hassan Elnaem, Siew Chin Ong
Clinicoeconomics and Outcomes Research : CEOR|July 21, 2025
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in ThailandUnchalee Permsuwan, Krit Leemasawat, Poukwan Arunmanakul
Clinicoeconomics and Outcomes Research : CEOR|December 22, 2025
Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill PatientsRui Martins, Jay Koyner, Ron Wald, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 14, 2025
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple MyelomaBhavesh Shah, Rickard Sandin, Yun Liu, et al.
Pageof 102